Overview

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate, on renal transplanted patients with CGD, the effect of two levels of haemoglobin on quality of life at 6 months and the speed of progression of renal function degradation at 24 months. This study will recruit 140 patients in 21 centers in France.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborator:
Roche Pharma AG